RYTM241115C30000
- 0.00
- 0.000.00%
Rhythm Pharmaceuticals Newsroom
A Quick Look at Today's Ratings for Rhythm Pharmaceuticals(RYTM.US), With a Forecast Between $59 to $80
A Quick Look at Today's Ratings for Rhythm Pharmaceuticals(RYTM.US), With a Forecast Between $64 to $72
Rhythm Pharmaceuticals Is Maintained at Buy by Needham
Rhythm Pharmaceuticals Analyst Ratings
Rhythm Pharmaceuticals: Strong Financial Performance and Pipeline Progress Justify Buy Rating
Morgan Stanley Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Maintains Target Price $55
Stifel Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Maintains Target Price $64
Wells Fargo Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Maintains Target Price $53
Needham Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Maintains Target Price $55
CCORF Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Maintains Target Price $77
Rhythm Pharmaceuticals Analyst Ratings
Strategic Collaborations and Regulatory Advancements Justify Buy Rating for Rhythm Pharmaceuticals
H.C. Wainwright Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Maintains Target Price $64
Guggenheim Initiates Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Announces Target Price $70
Rhythm Pharmaceuticals Is Maintained at Neutral by B of A Securities
Rhythm Pharmaceuticals Analyst Ratings
BofA Securities Maintains Rhythm Pharmaceuticals(RYTM.US) With Hold Rating, Raises Target Price to $52
Morgan Stanley Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Maintains Target Price $55
Wells Fargo Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Maintains Target Price $53
Wells Fargo Reaffirms Their Buy Rating on Rhythm Pharmaceuticals (RYTM)